LDS/Medical Tests/Liver Cytosolic Antigen Type 1 (LC-1) Antibody, IgG

Liver Cytosolic Antigen Type 1 (LC-1) Antibody, IgG

Liver Cytosolic Antigen Type 1 (LC-1) is a liver-specific protein from cytosol with a molecular weight of 240-290 kDa. It has been identified as formiminotransferase cyclodeaminase (FTCD), which contains two domains—the globular FT domain joined by a short linker to the CA domain. Immunoassays using recombinant antigen can be used to detect the presence of anti-LC-1 antibody in the serum sample.

Autoimmune hepatitis (AIH) is a rapidly progressive form of chronic hepatitis associated with the presence of autoimmune antibodies. It is a potentially fatal condition, but is rare with an annual incidence of 1.9 cases per 100,000 population. Detection of various autoantibodies is helpful in the differential diagnosis of AIH, which include antinuclear antibody (ANA), anti-smooth muscle antibody (ASMA), anti-liver-kidney microsomal antigen type-1 (anti-LKM-1), anti-liver cytosolic antigen type-1 (Anti-LC-1), and anti-soluble liver antigen (SLA).

Three form of AIH have been described on the basis of serological and clinical features. Type 1 which is the most common form is associated with ANA and/or ASMA. Type 2 AIH is more frequently seen in children and is characterized by the presence of Anti-LKM-1 or Anti-LC-1. Anti-LKM-1 is directed against cytochrome P450 2D6 (CYP2D6) and shows some degree of cross-reactivity to certain HCV antigens, resulting in false positive anti-LKM in the individuals with HCV infection.

In contrast, Anti-LC-1 is not associated with HCV infection and therefore is considered a more specific marker of type 2 AIH. However, anti-LC-1 is reported to be present in approximately 20% of patients with anti-LKM-1 positive AIH. Independent detection of Anti-LC-1 has limited clinical application, and is commonly tested along with Anti-LKM1 to increase diagnostic specificity. Type 3 AIH is associated with Anti-soluble liver antigen/liver pancreas (SLA) and often lacks other autoimmune markers.

  • Useful in differential diagnosis of autoimmune hepatitis of unknown etiology
  • Differential diagnosis of autoimmune hepatitis from infectious hepatitis

Positive (Detected) in:

  • Type 2 autoimmune hepatitis

Negative (Non-reactive)

Qualitative immunoblot.

Serum (SST).

Stability

  • Ambient: 1-3 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Liver-kidney microsome-1 antibody, IgG (Anti-LKM1), Soluble liver antigen (SLA) autoantibodies, Antinuclear antibody (ANA), antiactin, Smooth muscle antibody (SMA), Antineutrophil cytoplasmic antibodies (ANCA), Anti-asialoglycoprotein receptor (ASGPR), Anti-liver-pancreas antigen, Bilirubin, Albumin, Globulin, ALT, AST, ALP, γ-GT, IgG.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login